Effects on mRNA degradation by Escherichia coli transcription termination factor Rho and pBR322 copy number control protein Rop

Journal of Molecular Biology
S Sozhamannan, B L Stitt

Abstract

Mutants in Escherichia coli transcription termination factor Rho, termed rho(nusD), were previously isolated based on their ability to block the growth of bacteriophage T4. Here we show that rho(nusD) strains have decreased average half-lives for bulk cellular mRNA. Decreased E. coli message lifetimes could be because of increased ribonuclease activity in the rho mutant cells: if a Rho-dependent terminator precedes a ribonuclease gene, weaker termination in the rho mutants could lead to nuclease overexpression. However, inactivation of ribonuclease genes in rho026 cells did not relieve the defective phage growth. Unexpectedly, expression of the pBR322 Rop protein, a structure-specific, sequence-independent RNA-binding protein, in rho(nusD) cells restored the ability of T4 to grow and prolonged cellular message half-life in both the wild-type and the rho026 mutant. These results suggest that it is the RNA-binding ability of Rho rather than its transcription termination function that is important for the inhibition of bacteriophage growth and the shorter bulk mRNA lifetime. We propose that altered interaction of the mutant Rho with mRNA could make the RNA more susceptible to degradation. The inability of the RNA-binding proteins ...Continue Reading

References

Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A DasS Adhya
May 25, 1977·Journal of Molecular Biology·L P GuarenteJ Beckwith
May 20, 1977·Molecular & General Genetics : MGG·J P RichardsonM Macy
May 1, 1979·Virology·H Takahashi, H Yoshikawa
Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·L D SimonS Gottesman
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·R M BlumenthalS Pedersen
Oct 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C P EhretsmannH M Krisch
Dec 1, 1992·Microbiological Reviews·S Gottesman, M R Maurizi
Feb 1, 1992·Journal of Bacteriology·S L SullivanM E Gottesman
Feb 1, 1992·Molecular Microbiology·S R Schmid, P Linder
Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P Babitzke, S R Kushner
Feb 1, 1991·Molecular Microbiology·D Manen, L Caro
May 1, 1990·Genes & Development·E A MuddH M Krisch
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W P Donovan, S R Kushner
Jul 1, 1988·Journal of Bacteriology·K SkorupskiL D Simon
Dec 10, 1988·Gene·J G Belasco, C F Higgins
Jan 11, 1988·Nucleic Acids Research·R E Rose
Jun 16, 1971·Nature: New Biology·M KuwanoD E Morse
Jan 1, 1981·Molecular & General Genetics : MGG·R B Kent, S K Guterman
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·G CesareniB Polisky
Oct 1, 1984·Journal of Bacteriology·D D WombleR H Rownd
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A DasS Gottesman
Jan 25, 1983·Nucleic Acids Research·W P Donovan, S R Kushner
Jan 1, 1980·Molecular & General Genetics : MGG·Y N Zograff, A L Gintsburg
Mar 25, 1982·Journal of Molecular Biology·L R Finger, J P Richardson
Nov 10, 1994·Nature·I Iost, M Dreyfus

❮ Previous
Next ❯

Citations

Apr 16, 1998·Molecular Microbiology·D J O'Sullivan, T R Klaenhammer
Nov 13, 2001·Molecular Microbiology·B K SohanpalI C Blomfield
Mar 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Eric S MillerWolfgang Rüger
Oct 30, 2010·Virology Journal·Deborah M Hinton
Jan 23, 2016·Microbiology·Aleksandra Grylak-MielnickaElena Bidnenko
Apr 23, 2002·Molecular Microbiology·Valéria C S ItalianiMarilis V Marques
Jun 27, 2001·Journal of Biosciences·A Gulati, S Mahadevan
Jun 9, 2018·Viruses·Jennifer Patterson-WestDeborah M Hinton
May 9, 2021·Applied Microbiology and Biotechnology·Tomás G VillaAngeles Sánchez-Pérez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.